Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
52.61B | 50.84B | 48.21B | 49.50B | 53.11B | Gross Profit |
14.90B | 14.12B | 14.19B | 13.64B | 15.20B | EBIT |
1.30B | 350.72M | 1.23B | 1.62B | 1.75B | EBITDA |
3.70B | 2.11B | 2.97B | 3.38B | 3.56B | Net Income Common Stockholders |
1.07B | 9.90M | 741.10M | 1.22B | 1.23B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
12.34B | 12.21B | 13.53B | 12.73B | 13.32B | Total Assets |
57.61B | 54.91B | 52.76B | 53.80B | 50.81B | Total Debt |
3.36B | 3.63B | 3.18B | 3.20B | 2.86B | Net Debt |
-8.97B | -8.58B | -10.35B | -9.53B | -10.47B | Total Liabilities |
16.03B | 15.31B | 14.24B | 17.29B | 14.43B | Stockholders Equity |
39.26B | 36.66B | 35.79B | 33.87B | 33.71B |
Cash Flow | Free Cash Flow | |||
1.50B | -758.81M | 1.27B | 358.29M | 136.75M | Operating Cash Flow |
3.28B | 951.64M | 2.58B | 1.59B | 1.61B | Investing Cash Flow |
-1.23B | -1.18B | -811.51M | -1.08B | -1.72B | Financing Cash Flow |
-2.30B | -1.24B | -922.64M | -381.86M | -828.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $2.59T | 20.32 | 8.50% | 1.30% | 13.60% | 7.47% | |
71 Outperform | $368.75B | 9.28 | 15.22% | 1.99% | 6.63% | -13.82% | |
68 Neutral | ¥91.06B | 10.08 | 3.84% | 7.56% | 21.03% | ||
66 Neutral | ¥14.20B | 9.50 | 3.80% | 6.33% | 189.40% | ||
66 Neutral | ¥290.75B | 25.00 | 3.66% | 13.59% | 24.68% | ||
64 Neutral | ¥258.74B | 12.14 | 5.40% | 3.42% | 3.12% | ― | |
49 Neutral | $1.95B | -1.37 | -21.20% | 3.73% | 0.84% | -29.84% |